Brian Pittman, MS

  • 4Articles
  • 19.2KReads
  • 2010–2025Active
  • 18Collaborators
  • 180Citations

About

Brian Pittman, MS, is affiliated with the Department of Psychiatry at Yale University School of Medicine. His publications from 2010 to 2025 in Psychiatrist.com focus on clinical topics including addiction, bipolar disorder, eating disorders, obsessive-compulsive and related disorders, and psychotherapy. His work addresses treatments such as lisdexamfetamine and cognitive-behavioral therapy for binge-eating disorder, the use of levetiracetam in bipolar depression, and the impact of substance use on COVID-19 outcomes. He has also studied the onset and exacerbation of obsessive-compulsive disorder during pregnancy and the postpartum period.

Publications

JCP
Preference for Lisdexamfetamine vs CBT for Binge-Eating Disorder
Original Research

Preference for Lisdexamfetamine vs CBT for Binge-Eating Disorder

May 7, 2025

CBT and pharmacotherapy with lisdexamfetamine resulted in significant improvements in binge-eating disorder. Participants’ preferences for treatments were not associated with sociodemographic or clinical characteristics and did not moderate treatment...
, , , et al
JCP
Impact of SUD on COVID-19 Outcomes
Original Research

Impact of SUD on COVID-19 Outcomes

August 29, 2022

Identifying risk factors that predispose individuals to negative COVID-19 outcomes is important. The current study examined the association between substance use disorders, psychiatric diagnosis, and COVID-19–related clinical outcomes.
, , , et al
JCP
Original Research

Levetiracetam in the Management of Bipolar Depression: A Randomized, Double-Blind, Placebo-Controlled Trial

October 19, 2010

, , , et al
JCP
Article

Onset and Exacerbation of Obsessive-Compulsive Disorder in Pregnancy and the Postpartum Period

May 18, 2010

, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe